|
CN112105347A
|
|
Dosage forms for delivering drugs to the lower alimentary canal
|
|
CA3079929A1
|
|
Liquid filled formulations of pde5 inhibitors
|
|
EP3027216A1
|
|
Compositions and preparation methods of low melting ionic salts of poorly- water soluble drugs
|
|
US2014302132A1
|
|
Pharmaceutical composition comprising nanocrystals
|
|
GB201112578D0
|
|
Pharmaceutical preparation and use
|
|
GB201107652D0
|
|
Dosage Unit for Administration of Antibiotics to the Small and Large Intestine
|
|
GB0911826D0
|
|
Method and apparatus
|
|
GB0625180D0
|
|
Improved hard shell capsules
|
|
GB0525421D0
|
|
Improved hard shell capsules
|
|
GB0508692D0
|
|
Improved pharmaceutical and nutraceutical capsule
|
|
GB0506982D0
|
|
Abuse resistant capsules
|
|
GB0413818D0
|
|
Dosage unit
|
|
GB0320020D0
|
|
Improved formulation for providing an enteric coating material
|
|
GB0303113D0
|
|
Encapsulated flavouring for foods
|
|
GB0210737D0
|
|
Dispensing nozzle
|
|
EP1301178A2
|
|
Delivery device
|
|
GB0028335D0
|
|
Delivery device
|
|
GB0027954D0
|
|
Liquid filled capsules
|
|
GB0015523D0
|
|
Tamper-proof capsules
|
|
GB9915369D0
|
|
Capsule sealing system
|
